Polar Pharma India Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Sep ' 12	Mar ' 12	Sep ' 11	Mar ' 11	Sep ' 10

Sales

0.01

9.49

6.77

10.81

0.05

Operating profit

-2.43

0.29

-1.17

2.35

-0.65

Interest

8.13

7.92

7.15

6.94

6.32

Gross profit

-10.56

-7.55

-8.32

-4.50

-6.97

EPS (Rs)

-9.53

-7.07

-7.70

-4.57

-6.60

Other income

-

0.09

-

0.09

-

Stock adjustment

-0.05

0.41

1.32

-2.06

-

Raw material

0.09

3.61

3.20

5.66

-

Power and fuel

-

-

-

-

-

Employee expenses

1.47

1.58

1.49

1.34

0.27

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

0.93

3.61

1.93

3.52

0.42

Provisions made

-

-

-

-

-

Depreciation

1.12

1.13

1.13

1.10

1.13

Taxation

-

-

-

-

-

Net profit / loss

-11.69

-8.67

-9.45

-5.61

-8.10

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

12.27

12.27

12.27

12.27

12.27

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

86.21

86.21

86.21

86.21

86.21

Agg.of non promotoholding (%)

70.25

70.25

70.25

70.25

70.25

OPM (%)

-41213.56

3.03

-17.21

21.75

-1409.57

GPM (%)

-162529.23

-78.78

-

-41.34

-

NPM (%)

-179835.38

-90.56

-

-51.44

-